Profile
Nithya Desikan is currently Director at Corium LLC, Director at Paratek Pharmaceuticals, Inc., and Operating Partner at Gurnet Point Capital LLC.
Former roles include Vice President at Biogen, Inc. from 2016 to 2017, Chief Commercial Officer at Rhythm Pharmaceuticals, Inc. from 2017 to 2020, and Operating Partner at B Flexion Advisors UK LLP from 2022 to 2026.
Education includes undergraduate studies at the University of Florida.
Nithya Desikan active positions
| Companies | Position | Start |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Director/Board Member | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Director/Board Member | - |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | - |
Former positions of Nithya Desikan
| Companies | Position | End |
|---|---|---|
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Private Equity Investor | 01/06/2026 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30/09/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2017 |
Training of Nithya Desikan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Finance |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
- Stock Market
- Insiders
- Nithya Desikan
















